Table of contents

• Stem Cell Treatments for Sexual Performance at a Glance
• What Are Stem Cell Treatments for Sexual Performance?
• Who Is a Good Candidate for Stem Cell Treatments for Sexual Performance?
• How Are Stem Cell Treatments for Sexual Performance Performed?
• Why Visit Korea for Stem Cell Treatments for Sexual Performance?
• Key Information for International Patients
• Which Are the Best Clinics in Korea for Stem Cell Treatments For Sexual Performance?
• Stem Cell Treatments for Sexual Performance From Start to Finish
• Alternatives to Stem Cell Treatments for Sexual Performance
• How Can I Prepare for Stem Cell Treatments for Sexual Performance?
• Aftercare Advice

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

Last updated: September 2026

Stem Cell Treatments for Sexual Performance at a Glance

• Investigational treatment — Stem cell treatment for sexual performance is not an established therapy; human research mainly examines intracavernosal cell injections for male organic erectile dysfunction, not enhancement of normal erections, libido, stamina, orgasm, fertility, or penile size.
• No standard protocol — Research approaches differ by cell source, processing, dose, injection site, number of sessions, and quality controls; some use a penile injection alone, while autologous fat- or bone-marrow-based protocols also require liposuction or marrow collection.
• Results are uncertain — No validated onset time, final-result date, durability period, or maintenance schedule exists. Early studies generally measure erectile-function questionnaires over weeks to months, and current evidence is insufficient for routine clinical use.
• Best-fit research candidates — Studies have focused on adults with clinically diagnosed, bothersome organic ED, including vasculogenic, diabetes-associated, or post-prostatectomy ED, after urologic and cardiovascular assessment and discussion of established treatments.
• Important risks — Potential harms include penile pain, bleeding, bruising, swelling, hematoma, infection, fibrosis, prolonged erection, and no benefit; liposuction, marrow harvest, sedation, or anesthesia add separate procedural risks.
• Korea authorization check — South Korea regulates regenerative-medicine research and cell products, but no official evidence was found of MFDS market authorization for a stem-cell product to treat ED or general sexual-performance enhancement; request the exact trial or authorization pathway in writing.
• Travel cannot be standardized — There is no evidence-based minimum stay in Korea or long-haul flight-clearance interval. Travel plans must accommodate protocol observation, possible harvest recovery, emergency access, and named Korean and home-country clinicians for follow-up.

What Are Stem Cell Treatments for Sexual Performance?

Stem cell treatments for sexual performance are investigational cell-based interventions studied mainly as penile injections for male erectile dysfunction. They aim to improve erections in people with diagnosed ED, but reliable benefits, timing, and durability remain unproven. These treatments are minimally invasive when delivered by injection, though fat or bone-marrow collection adds a separate procedure.

Who Is a Good Candidate for Stem Cell Treatments for Sexual Performance?

• Potential research population — Adults with clinically diagnosed, bothersome organic erectile dysfunction (ED), including vasculogenic, diabetes-associated, or post-prostatectomy ED, are the groups studied in early cell-therapy research.
• Diagnosis-first candidates — Consider investigational treatment only after assessment of ED duration, erection hardness, medical and sexual history, cardiovascular risk, medicines, and response to established treatment.
• Study participation — A properly approved clinical study or transparently authorized pathway must state its eligibility criteria, product details, consent process, safety monitoring, and follow-up requirements.

This is not an elective enhancement treatment for normal erectile function, libido, stamina, orgasm, ejaculation, fertility, or penile size. A proper ED assessment includes blood pressure, BMI, glucose or HbA1c, lipids, fasting early-morning total testosterone, and selected tests such as PSA, prolactin, LH, or penile duplex Doppler; ED can be an early marker of cardiovascular disease. Defer treatment and sexual activity pending cardiovascular assessment with unstable angina, uncontrolled hypertension, NYHA class-IV heart failure, myocardial infarction without intervention in the preceding 2 weeks, or high-risk arrhythmia. Active infection, bleeding risk, inability to undergo injection or harvest safely, and inability to complete follow-up require protocol-specific review. Evidence is inadequate for female sexual dysfunction and for sexual concerns driven by pain, relationship distress, trauma, medication effects, hormonal disease, or low desire.

How Are Stem Cell Treatments for Sexual Performance Performed?

“Stem cell treatment” is not one standardized procedure. Research products differ in source, processing, dose, manufacturing controls, immune risk, route, and legal status; no validated cell characterization, injection site, number of injections, or co-treatment regimen exists.

• Autologous adipose-derived cells — Fat is collected by liposuction, then a regenerative cell fraction or cultured cells are processed before intracavernosal injection into the corpora cavernosa. This adds liposuction recovery and, in some protocols, sedation or anesthesia to the penile injection.
• Autologous bone-marrow-derived cells — Marrow is collected and processed before penile injection. A Korean phase-I study enrolled only 10 men with diabetes-associated or post-prostatectomy ED and was designed primarily for safety, not proof of effectiveness, as described in the trial report.
• Donor-derived mesenchymal-cell products — Umbilical-cord, placental, or other donor-derived cells avoid a harvest procedure but introduce different donor-screening, traceability, immune, and manufacturing questions.
• Exosome or secretome products — These acellular products are marketed as cell-derived signals rather than living cells. They are not interchangeable with stem cells and do not have an established ED treatment role.
• Intracavernosal delivery — Credible human ED studies generally use sterile injection into erectile tissue. This is not the same as intravenous “stem cell” treatment, and an IV route should not be presented as an evidence-based ED protocol.

Why Visit Korea for Stem Cell Treatments for Sexual Performance?

South Korea has formal frameworks for advanced regenerative medicine research and cell-therapy product oversight. That framework does not establish stem-cell treatment as routine care for ED or general sexual performance. This dossier found no official evidence of MFDS market authorization for a stem-cell product indicated for ED, libido, orgasm, ejaculation, female sexual dysfunction, or enhancement.

• Regulatory structure — The MFDS regulatory framework covers evaluation of quality, safety, and efficacy for cell and gene therapy products, as well as investigational and marketing-authorization pathways.
• Research infrastructure — Korea’s advanced-regenerative-medicine system provides for designated institutions, reviewed research plans, safety management, and long-term follow-up where applicable. Ask the provider to document the exact pathway rather than relying on marketing language.
• Relevant Korean research — The multicenter Korean Cellgram-ED phase-II study involved 54 participants with ED after radical prostatectomy and lists completion on January 7, 2026. Its completed registry record does not demonstrate efficacy, approval, current availability, or international-patient eligibility.
• Authorization claims require proof — MFDS material identifies Cellgram-AMI as an approved cell product for acute myocardial infarction while describing ED as a clinical-trial area in its English product information. Require written evidence when a provider claims an ED product is approved or authorized.

Key Information for International Patients

• Minimum stay — No evidence-based minimum stay exists for this indication. Do not plan around a same-day injection; the written protocol must specify observation, local emergency access, and required in-person follow-up.
• Flight timing — There is no validated long-haul flight-clearance interval after penile cell injection. Flight timing depends on bleeding risk, pain, complications, sedation, and whether fat harvest or bone-marrow collection was performed.
• Harvest procedures — Liposuction, marrow collection, sedation, or anesthesia make this more than a simple outpatient injection visit and require separate recovery, transport, and accommodation planning.
• Repeat visits and results — No validated benefit-onset, durability, maintenance schedule, or repeat-injection interval exists. Studies generally assess erectile-function questionnaires over weeks to months rather than proving an immediate or reliable result.
• Remote follow-up — Travel only with named Korean and home-country clinicians, a shared adverse-event plan, and the same baseline outcome questionnaire, such as IIEF or SHIM, for follow-up reporting.
• Itinerary impact — Keep plans flexible. Avoid commitments that prevent urgent urologic or emergency assessment, and arrange accessible lodging near the treating institution.

Travel note: Leave Korea only after receiving an English discharge summary, procedure note, product name and source, dose and route, emergency contact details, and records that a home urologist can use.

Which Are the Best Clinics in Korea for Stem Cell Treatments For Sexual Performance?

Listed below are some of the best clinics in Korea for stem cell treatments for sexual performance.

1. SH Clinic

SH Clinic specifically includes personalized stem cell treatment for male and female sexual function, making it a relevant option if you are seeking an in-person assessment for sexual-health concerns and a plan tailored to your individual needs and examination findings.

• URL: SH Clinic Website
• Location: Seocho-gu, Seoul
• Sexual-health focus:
  • Offers stem cell treatment programs addressing male sexual function and female health and sexual function.
  • Frames treatment planning around sexual performance and satisfaction according to your individual needs.
• Consultation and planning:
  • Personalized treatment is provided after an in-person consultation and examination by experienced medical staff.
  • Its Wellness & Anti-aging Program is based on the clinic’s clinical experience with individualized stem cell treatments.
• Related women’s health services: Provides gynecologic care and vaginal rejuvenation options, including stem cell injections, vaginal fillers, HIFU laser treatment, vaginal tightening, and implant surgery.

2. THEPLUS Plastic Surgery

THEPLUS Plastic Surgery may be worth considering if you are exploring a blood-derived regenerative treatment protocol: the clinic describes a Buffy Coat extraction system designed to obtain a concentrated cell layer from a 60 cc blood sample for a single application. The supplied information does not specifically identify sexual performance as a treatment indication, so you should clarify whether your concern is evaluated and treated there.

• URL: THEPLUS Plastic Surgery Website
• Location: Gangnam-gu, Seoul
• Stem cell protocol details:
  • Describes extraction of the Buffy Coat layer from blood, with the clinic stating that the system secures more than 10% of the sampled blood.
  • States that 60 cc of blood is used to obtain sufficient Buffy Coat for a complete single-application treatment.
  • Describes individually sterilized and packaged components and an individually included 30 ml anticoagulant.
• Product claims to clarify:
  • The clinic describes its stem cell kit and anticoagulant as U.S.-manufactured and FDA-approved; ask what specific product, clearance or approval, and intended use apply to your proposed treatment.
  • The available information presents stem cell treatment within a broader aesthetic and post-procedure care approach rather than describing a sexual-function program.

3. Cellinique Clinic

Cellinique Clinic may be a consideration if you are seeking physician-led, personalized regenerative care built around autologous blood-based and stem-cell approaches. Its available information emphasizes immunity, tissue regeneration, and overall health, but does not specifically list sexual performance as an indication, so you should confirm whether it offers an appropriate evaluation for your goals.

• URL: Cellinique Clinic Website
• Location: Gangnam-gu, Seoul
• Regenerative approaches:
  • Offers NovaStem, described as using concentrated autologous blood to support activation of aged cells and tissue regeneration.
  • Lists stem cell therapy for tissue repair, metabolic support, and overall health, alongside PRP, exosomes, NK cell therapy, and stem cell fat grafting.
• Physician and research activity:
  • Operates as a one-doctor clinic dedicated to stem cell research, with personalized consultations and customized treatment plans.
  • Dr. Chris Gunwoo Kim lectured in 2024 on high-concentration blood cell zones and SDF-1alpha injection and presented the clinic’s NovaStem Kit at a 2025 KOAT spring conference.
• Scope to clarify: The supplied information focuses on regeneration, immunity, aesthetic care, and overall health rather than a defined sexual-performance treatment program.

Stem Cell Treatments for Sexual Performance From Start to Finish

1. Written inquiry and virtual consultation — Request an English-language or interpreter-supported consultation. Ask whether the service is a registered clinical study or another authorized pathway, and obtain the trial registration, IRB approval or authorization status, investigator name, institution, product name, and full follow-up plan in writing.
2. Urologic and cardiovascular assessment — A sexual-medicine clinician reviews ED severity, IIEF or SHIM scores, erection hardness, prior response to sildenafil, tadalafil, vacuum devices, alprostadil, or injection therapy, plus cardiovascular, diabetes, prostate-cancer, and medication history. Testing commonly includes blood pressure, BMI, glucose or HbA1c, lipids, and fasting morning testosterone; further tests depend on clinical findings.
3. Protocol and product verification — Confirm whether cells are autologous or donor-derived; whether they are minimally manipulated or culture-expanded; and what release testing covers identity, viability, sterility, endotoxin, and mycoplasma where applicable. Confirm dose, route, number of planned administrations, donor screening and traceability, adverse-event coverage, and who manages complications after return home.
4. Travel and consent planning — Schedule travel only after the team confirms required observation and in-person visits. Review consent carefully: early studies do not establish a reliable response, final-result date, durability, or retreatment schedule.
5. Collection and processing when applicable — Autologous adipose protocols add fat harvest/liposuction and processing. Bone-marrow protocols add marrow collection. These steps determine whether local or general anesthesia, sedation, fasting, a companion, and additional recovery are required.
6. Intracavernosal administration — The team verifies product identity, prepares the area aseptically, and injects the protocol-specified product into the corpora cavernosa. Staff monitor for pain, bleeding, swelling, hematoma, allergic symptoms, and prolonged erection during the stated observation period.
7. Discharge and local recovery — Leave only when the protocol team clears discharge. Receive written instructions on bathing, pressure, exercise, sexual activity, medicines, emergency care, and travel; do not drive after sedation or anesthesia.
8. Overseas safety follow-up — Complete the agreed remote reviews and questionnaire assessments with the Korean team and a home urologist. Report complications promptly rather than waiting for a scheduled result assessment.

Alternatives to Stem Cell Treatments for Sexual Performance

Established ED care has clearer benefits, risks, and follow-up expectations than investigational cell therapy. Non-surgical choices can be effective but require ongoing use or repeated treatment; penile prosthesis surgery is invasive and permanent but is an established option for selected refractory ED.

Medical ED Assessment and PDE5 Inhibitors

• First-line pathway — Address cardiovascular risk factors, diabetes control, smoking, medicines, psychological contributors, and relationship factors alongside medical treatment.
• Medication options — Sildenafil and tadalafil are established PDE5 inhibitors when medically appropriate. Do not combine them with nitrates; a clinician must assess cardiovascular fitness and drug interactions. See erectile dysfunction treatment.

Vacuum Devices and Alprostadil

• Vacuum erection device — A mechanical option that produces an erection with negative pressure and a constriction ring; it avoids systemic PDE5-inhibitor effects but requires planning and correct use.
• Injection or urethral medicine — Alprostadil, alone or in combination injection regimens, can help when tablets are ineffective or unsuitable. Training is essential because priapism and penile pain are recognized risks.

Testosterone Treatment

• Appropriate indication — Testosterone is used for confirmed hypogonadism, supported by symptoms and appropriate testing; it is not a general sexual-performance treatment. Review testosterone injection only after endocrine assessment.

Penile Prosthesis

• Surgical option for refractory ED — An inflatable or malleable implant can provide dependable rigidity when less invasive therapies fail or are unacceptable. Surgery has irreversible anatomical and device-related tradeoffs; review penile implant surgery.

Platelet-Rich Plasma

• Another marketed regenerative option — PRP is also promoted for ED, but it has separate evidence limitations and should not be represented as a proven equivalent to established ED treatment. See PRP injection.

How Can I Prepare for Stem Cell Treatments for Sexual Performance?

• Complete the diagnostic work-up first — Do not use an experimental intervention to bypass evaluation of cardiovascular disease, diabetes, hypogonadism, medication effects, pelvic or prostate treatment history, or psychological and relationship contributors.
• Disclose every substance — Provide a complete list of prescription medicines, over-the-counter drugs, PDE5 inhibitors, testosterone, nitrates, antihypertensives, diabetes medicines, anticoagulants, antiplatelets, NSAIDs, supplements, and recreational drugs. Include fish oil/omega-3, vitamin E, ginkgo, garlic, ginseng, St John’s wort, and sexual-enhancement products; some enhancement products contain undeclared drug ingredients.
• Do not stop medicines independently — The prescribing clinician and protocol team must direct any anticoagulant, antiplatelet, NSAID, diabetes-drug, or hormone adjustment. This is especially important when injection, liposuction, marrow harvest, or anesthesia is planned.
• Follow fasting instructions precisely — Fasting may be needed for early-morning testosterone, glucose, or lipid testing. A penile injection itself does not inherently require fasting; sedation, anesthesia, liposuction, and marrow collection do.
• Plan transport and lodging — Arrange nearby accommodation, avoid driving after sedatives or anesthesia, and bring a responsible adult companion when required by the anesthesia plan, harvest procedure, mobility limits, or language needs.
• Keep flights flexible — Do not book a rigid departure before the team specifies observation and flight timing. Avoid alcohol and recreational drugs when required by the protocol or sedation plan.

Travel note: Obtain a written cross-border complication plan before paying for travel, including the clinician responsible for remote review and emergency reporting after return home.

Confirm all clinic- and protocol-specific requirements with the treating doctor; individualized instructions take precedence over general guidance.

Aftercare Advice

Treat new penile symptoms or systemic illness after an investigational cell intervention as a medical issue, not a normal “regenerative” reaction.

• Observation and records — Complete the protocol’s observation period before leaving. Keep the English discharge summary, product details, procedure note, medication list, and 24-hour contact number accessible during travel.
• Activity and sexual restrictions — Follow the written directions for walking, exercise, lifting, bathing, pressure on harvest sites, and sexual activity. Restrictions depend on injection depth, bleeding risk, liposuction or marrow collection, and sedation—not on a universal timetable.
• Injection and harvest-site care — Keep sites clean and follow the team’s instructions on dressings, showering, compression, and pain medicines. Do not massage, puncture, or apply unapproved products to the penis or collection area.
• Urgent warning signs — Seek urgent assessment for an erection lasting 4 hours or more, severe or escalating penile pain, major bleeding, rapidly increasing swelling, fever, spreading redness, discharge, urinary retention, fainting, chest pain, shortness of breath, or allergic symptoms.
• Follow-up and expectations — Complete scheduled safety reviews and the same validated ED questionnaire used at baseline. There is no validated final-result date, durability period, or maintenance-injection schedule; the current evidence remains insufficient for routine implementation.

Follow the treating doctor’s individualized instructions and contact the clinic immediately when something appears wrong.